XML 27 R11.htm IDEA: XBRL DOCUMENT v3.26.1
Marketable Securities and Fair Value Measurements
3 Months Ended
Mar. 31, 2026
Debt Securities [Abstract]  
Marketable Securities and Fair Value Measurements
NOTE 4. Marketable Securities and Fair Value Measurements
Marketable Securities
The following table summarizes the Company’s marketable securities (in thousands):
 March 31, 2026December 31, 2025
 Amortized CostGross Unrealized GainsGross Unrealized Losses Fair ValueAmortized CostGross Unrealized GainsGross Unrealized Losses Fair Value
Corporate debt securities$— $— $— $— $6,991 $$— $6,997 
U.S. Treasury notes91,072 352 — 91,424 103,620 813 (1)104,432 
 $91,072 $352 $— $91,424 $110,611 $819 $(1)$111,429 
For the three months ended March 31, 2026, the Company recognized total interest income (included in other income (expense), net in the condensed consolidated statements of operations) of $2.8 million, of which $1.6 million was related to its marketable securities investments and $1.2 million was related to interest on cash and cash equivalent balances. For the three months ended March 31, 2025, the Company recognized total interest income (included in other income (expense), net in the condensed consolidated statements of operations) of $4.3 million, of which $3.1 million was related to its marketable securities investments and $1.2 million was related to interest on cash and cash equivalent balances.
The following table summarizes the Company’s marketable securities maturity as of March 31, 2026 (in thousands):
YearAmortized CostFair Value
2026$38,435 $38,561 
202727,976 28,095 
202824,661 24,768 
 $91,072 $91,424 
The Company had no marketable securities with gross unrealized losses as of March 31, 2026. The following table summarizes the Company’s marketable securities with gross unrealized losses by security type aggregated by the length of time the investments have been in a continuous unrealized loss position as of December 31, 2025 (in thousands):
Less Than 12 Months12 Months or Greater
Fair ValueGross Unrealized Losses Fair ValueGross Unrealized Losses
Corporate debt securities$— $— $— $— 
U.S. Treasury notes12,932 — — 
$12,932 $$— $— 
The Company’s unrealized losses from marketable securities as of December 31, 2025 were caused primarily by interest rate increases. As of March 31, 2026, all of the Company’s marketable securities carry an investment grade rating by nationally recognized statistical rating organizations. There was no allowance for credit losses on available-for-sale marketable securities at March 31, 2026 or December 31, 2025.
Fair Value Measurements
The Company’s financial instruments consist of cash and cash equivalents, restricted cash and equivalents, marketable securities, receivables, other liabilities, accounts payable, certain accrued expenses, and borrowings which consist of a term loan and a revolving credit facility. The carrying values of the financial instruments classified as current in the consolidated balance sheets approximate their fair values due to their short-term maturities. The fair values of the term loan and revolving credit facility approximate the carrying values because the interest rates on such borrowings approximate market rates as of the reporting date. Such borrowings are classified within Level 2 of the fair value hierarchy. During the three months ended March 31, 2026 and 2025, there were no material transfers of financial assets or liabilities within the fair value hierarchy.
The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:
Level 1—quoted prices for identical instruments in active markets;
Level 2—quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
Level 3—fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The table below summarizes the Company’s financial instruments measured at fair value on a recurring basis (in thousands):
 March 31, 2026December 31, 2025
 Level 1Level 2Level 3Level 1Level 2Level 3
Marketable securities:
Corporate debt securities$— $— $— $— $6,997 $— 
U.S. Treasury notes91,424 — — 104,432 — — 
 $91,424 $— $— $104,432 $6,997 $—